Citigroup’s Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock ARCK Stock Holding History

Citigroup’s Portfolio ARCK Stock Details ARCK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-42,801	Closed	-$433K	–	6116
2022 Q3	$433K	Hold	42,801	–	–	﹤0.01%	3344
2022 Q2	$429K	Buy	+42,801	New	+$430K	﹤0.01%	3353

Other funds holding ARCK

WAM

Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Citigroup's ARCK Position: Q4 2022 in Review

Citigroup sold out of Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock (ARCK) in Q4 2022, closing a stake of 42,801 shares — an estimated $433K sold.

Citigroup first reported a position in ARCK in Q2 2022 and held it in 2 quarters. The position peaked at $433K in Q3 2022. 2 funds tracked by Wall St. Rank hold ARCK as of Q4 2022.

Citigroup reported no remaining Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock position as of Q4 2022 after selling out during the quarter.
Citigroup sold 42,801 Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock shares in Q4 2022, an estimated $433K.
Citigroup first reported a position in Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock in Q2 2022 and held it in 2 quarters.
Citigroup's Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock position peaked at $433K in Q3 2022.
2 funds tracked by Wall St. Rank held Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock as of Q4 2022.

Based on Citigroup's 13F filing for Q4 2022, filed 9 Feb 2023.